Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial

BACKGROUND: There is no effective treatment for women with unexplained recurrent pregnancy loss (RPL). We aimed to investigate whether treatment with a high dose of intravenous immunoglobulin (IVIG) in early pregnancy can improve pregnancy outcomes in women with unexplained RPL. METHODS: In a double...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Hideto, Deguchi, Masashi, Saito, Shigeru, Takeshita, Toshiyuki, Mitsui, Mari, Saito, Tsuyoshi, Nagamatsu, Takeshi, Takakuwa, Koichi, Nakatsuka, Mikiya, Yoneda, Satoshi, Egashira, Katsuko, Tachibana, Masahito, Matsubara, Keiichi, Honda, Ritsuo, Fukui, Atsushi, Tanaka, Kanji, Sengoku, Kazuo, Endo, Toshiaki, Yata, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251568/
https://www.ncbi.nlm.nih.gov/pubmed/35795714
http://dx.doi.org/10.1016/j.eclinm.2022.101527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251568/
https://www.ncbi.nlm.nih.gov/pubmed/35795714
http://dx.doi.org/10.1016/j.eclinm.2022.101527

Ejemplares similares